KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sabra Health Care REIT (SBRA) EBITDA Margin (2016 - 2025)

Sabra Health Care REIT (SBRA) has 10 years of EBITDA Margin data on record, last reported at 10.45% in Q4 2025.

  • For Q4 2025, EBITDA Margin fell 3081.0% year-over-year to 10.45%; the TTM value through Dec 2025 reached 34.33%, down 606.0%, while the annual FY2025 figure was 34.33%, 28.0% down from the prior year.
  • EBITDA Margin reached 10.45% in Q4 2025 per SBRA's latest filing, down from 55.02% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 162.66% in Q1 2022 and bottomed at 31.99% in Q4 2023.
  • Average EBITDA Margin over 5 years is 52.66%, with a median of 37.14% recorded in 2024.
  • Peak YoY movement for EBITDA Margin: surged 12095bps in 2022, then plummeted -14991bps in 2023.
  • A 5-year view of EBITDA Margin shows it stood at 9.17% in 2021, then surged by 415bps to 28.91% in 2022, then tumbled by -211bps to 31.99% in 2023, then soared by 229bps to 41.26% in 2024, then crashed by -75bps to 10.45% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 10.45% in Q4 2025, 55.02% in Q3 2025, and 117.37% in Q2 2025.